Please assess the completion status of the following clinical trial:

Trial Title: Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 20 to 40 years of age~* Have a body mass index 25-40 kg/m2~* Have a sedentary lifestyle (participated in less than 30 minutes of physical activity 3 days per week over the last 6 months)~* History of irregular menstrual cycles (fewer than 6 cycles in past year)~* Excess androgen (to be measured at screening)~* Willing to supplement normal diet with cinnamon extract and a placebo for 12 weeks~* You can stay overnight at Pennington Center three times over the next six months~Exclusion Criteria:~* Do not meet our diagnostic criteria for polycystic ovary syndrome~* Have heart disease, lung disease, liver disease, blood disease, kidney disease, type 1 or 2 diabetes, or any other disease that in the opinion of the doctor might make you ineligible.~* Have cancer (active malignancy with or without concurrent chemotherapy).~* Abuse alcohol or illegal drugs.~* Smoke or have smoked within the previous 6 months. No smoking will be permitted during the study.~* Have donated blood within 30 days prior to randomization date.~* Have a hemoglobin, hematocrit, red blood cell, or iron level below the normal lower limit at screening.~* Taking medications that alter your glucose metabolism, (30 minute or more, 4 or more times per week over the past year.)~* Unwilling or unable to adhere to the clinical evaluation schedule over the entire six-month follow-up period.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Cinnamon Supplementation (Type: ACTIVE_COMPARATOR): A 500mg (consumed as two, 250mg capsules) of cinnamon extract (Cinnamon Bark P.E\> 20:1) will be consumed before meals, three times per day.
- Placebo (Type: PLACEBO_COMPARATOR): A 500 mg placebo (wheat flour) will be consumed before meals, three times per day.

Based on this trial design, predict the completion outcome and termination type (if applicable).